[HTML][HTML] KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer

J Cicenas, K Kvederaviciute, I Meskinyte… - Cancers, 2017 - mdpi.com
Pancreatic cancer is a disease that has a very high fatality rate and one of the highest
mortality ratios among all major cancers, remaining the fourth leading cause of cancer …

[HTML][HTML] Pathogenesis of pediatric B‑cell acute lymphoblastic leukemia: Molecular pathways and disease treatments

FL Huang, EC Liao, CL Li, CY Yen… - Oncology …, 2020 - spandidos-publications.com
B‑cell acute lymphoblastic lymphoma (B‑ALL) is a disease found mainly in children and in
young adults. B‑ALL is characterized by the rapid proliferation of poorly differentiated …

[HTML][HTML] Histone H3K27M mutation overrides histological grading in pediatric gliomas

A Mosaab, M El-Ayadi, EN Khorshed, N Amer… - Scientific reports, 2020 - nature.com
Pediatric high-grade gliomas (HGG) are rare aggressive tumors that present a prognostic
and therapeutic challenge. Diffuse midline glioma, H3K27M–mutant is a new entity …

[HTML][HTML] Small molecule KRAS agonist for mutant KRAS cancer therapy

K Xu, D Park, AT Magis, J Zhang, W Zhou, GL Sica… - Molecular Cancer, 2019 - Springer
Background Lung cancer patients with KRAS mutation (s) have a poor prognosis due in part
to the development of resistance to currently available therapeutic interventions …

Childhood cancer care in the Middle East, North Africa, and West/Central Asia: a snapshot across five countries from the POEM network

M Basbous, M Al-Jadiry, A Belgaumi, I Sultan… - Cancer …, 2021 - Elsevier
Abstract Background The Pediatric Oncology East and Mediterranean (POEM) network,
through this report, provides a snapshot view of an expected child's treatment journey in five …

Prognostic stratification of molecularly and clinically distinct subgroup in children with acute monocytic leukemia

LP Liu, AL Zhang, M Ruan, LX Chang, F Liu… - Cancer …, 2020 - Wiley Online Library
Background The prognosis of children with acute monocytic leukemia (AML‐M5) remains
unsatisfactory and the risk profile is still controversial. We aim to investigate the prognostic …

Treatment of childhood acute lymphoblastic leukemia in Iraq: a 17-year experience from a single center

SA Al-Hadad, MF Al-Jadiry, HH Ghali… - Leukemia & …, 2021 - Taylor & Francis
We performed a retrospective analysis of 1415 acute lymphoblastic leukemia children
diagnosed between January 2000 and December 2016 at Children Welfare Teaching …

High-selectivity single-nucleotide variant capture technology based on the DNA reaction network

W Tang, Y Zhang, J Wang, Y Zhao, X Xu, C Liu… - Analytical …, 2022 - ACS Publications
The extremely low abundance of circulating tumor DNA in blood samples has limited the
development of liquid biopsy techniques for the early diagnosis of major diseases. In this …

High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR‐ABL1‐like acute lymphoblastic leukemia

JW Lee, Y Kim, B Cho, S Kim, PS Jang, J Lee… - Cancer …, 2020 - Wiley Online Library
Introduction Recent advances in genetic analysis have led to the discovery of novel genetic
subtypes of precursor B‐cell acute lymphoblastic leukemia (B‐ALL) with prognostic …

[HTML][HTML] Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia

D Shen, L Liu, X Xu, H Song, J Zhang, W Xu, F Zhao… - BMC pediatrics, 2023 - Springer
Purpose The 5-year survival rate of children with acute lymphoblastic leukemia (ALL) is 85–
90%, with a 10–15% rate of treatment failure. Next-generation sequencing (NGS) identified …